0001140361-13-012273.txt : 20130313
0001140361-13-012273.hdr.sgml : 20130313
20130313160104
ACCESSION NUMBER: 0001140361-13-012273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130311
FILED AS OF DATE: 20130313
DATE AS OF CHANGE: 20130313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASAR VINIT K
CENTRAL INDEX KEY: 0001454324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 13687479
MAIL ADDRESS:
STREET 1: HANGER ORTHOPEDIC GROUP, INC.
STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2013-03-11
0
0000722723
HANGER, INC.
HGR
0001454324
ASAR VINIT K
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
1
0
0
Chief Executive Officer
Common Stock
2013-03-11
4
A
0
18500
0
A
126050
D
Common Stock
2013-03-12
4
S
0
2970
29.5581
D
123080
D
The restricted stock being reported does not include the contingent right of the reporting person to receive up to 18,500 additional performance shares under the issuer's 2010 Omnibus Incentive Plan based on the achievement of certain performance targets for the fiscal year 2013.
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $29.53 to $29.61. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 18,500 shares of stock from an initial grant of 18,500 shares of restricted stock made on March 11, 2013; (ii) unvested restricted shares totaling 17,250 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (iii) unvested restricted shares and fully vested shares totaling 24,630 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (iv) unvested restricted shares and fully vested shares totaling 14,451 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (v) unvested restricted shares and fully vested shares totaling 19,247 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and [continued in next footnote]
(vi) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar
2013-03-13